PrimeX News

Oil News: Crude Oil Outlook Sours as Physical Discounts Spread Globally
Thu, 25 Jun 2026 03:54:43 GMT
Oil Price Forecast: WTI Breaks $80 as Brent Targets $68 Support
Thu, 25 Jun 2026 03:40:10 GMT
Sandisk (SNDK) Price Forecast: AI Rally Faces Key Pullback Test
Wed, 24 Jun 2026 21:04:01 GMT
Gold (XAU/USD) Price Forecast: Breakdown Signals Risk of Deeper Correction
Wed, 24 Jun 2026 20:55:51 GMT
Natural Gas Price Forecast: Breakdown Risk vs Resistance Test
Wed, 24 Jun 2026 20:46:44 GMT
NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Retreats Ahead Of Micron’s Earnings
Wed, 24 Jun 2026 19:48:03 GMT

First Light News: Trump Puts Pen to Paper & the Fed Comes in Hawkish
Thu, 18 Jun 2026 08:20:37 GMT
ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 11 Jun 2026 17:21:35 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Thu, 11 Jun 2026 17:22:50 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 11 Jun 2026 17:20:25 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Thu, 11 Jun 2026 17:22:12 GMT

Seasonality and Event-Driven Trades in ETFs: How to Spot Recurring Trading Opportunities
Fri, 19 Jun 2026 23:26:11 GMT
Building and Risk-Managing Multi-Asset Portfolios with ETFs
Fri, 19 Jun 2026 20:08:58 GMT
What Really Drives ETF Performance: Rebalancing, Dividends, Fees, and Tracking Error
Tue, 23 Jun 2026 13:26:26 GMT
Trading Volume Explained: Why it Matters for Breakouts, Reversals and Trends
Wed, 10 Jun 2026 00:40:01 GMT
RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT

Advertisement

Advertisement

RNAZ

TransCode Therapeutics, Inc. Common Stock

4.89

USD

+0.04

+0.82%

Jun 24, 16:00 UTC -4

Closed

exchange

After-Market

4.91

+0.01

+0.20%

RNAZ News & Forecasts

featured

TransCode Therapeutics, Inc. (RNAZ) Discusses Strategic, Scientific, and Clinical Updates With Focus on TTX-MC138 Phase 2a Trial in Colorectal Cancer Prepared Remarks Transcript

Advertisement

Advertisement

Advertisement